An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
Titel:
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
Auteur:
Capri, G. Chang, J. Chen, S.-C. Conte, P. Cwiertka, K. Jerusalem, G. Jiang, Z. Johnston, S. Kaufman, B. Link, J. Ro, J. Schütte, J. Oliva, C. Parikh, R. Preston, A. Rosenlund, J. Selzer, M. Zembryki, D. De Placido, S.